Nov 30, 2022 / 02:00PM GMT
Jason M. Bednar - Piper Sandler & Co., Research Division - VP & Senior Research Analyst
Right. Good morning, everybody. Thanks for joining us today. I'm Jason Bednar. I cover med tech here at Piper. Next fireside chat is with Henry Schein. Very happy to have with us today Henry Schein's CEO, Stanley Bergman; and CFO, Ron South. Thanks a lot for being here, both of you really appreciate it.
Questions and Answers:
Jason M. Bednar - Piper Sandler & Co., Research Division - VP & Senior Research AnalystMaybe why don't we get right into Q&A, Stan. I always love your perspective on the dental market. And don't worry, we'll talk about the medical business. I don't want to -- we're not going to ignore it. But let's start with dental. It really seems like the theme emerging over the past few months from your commentary and the commentary from others is stability. It's not just the U.S., but other geographic markets really sound stable as well. I got that impression from checking in with several companies at the Greater New York Meeting yesterday